Intriguingly, colorectal cancer cells lacking Nt-me3 of CENP-A acquire a p53-dependent growth advantage in vitro and in vivo, implying an anti-oncogenic potential of NTMT1-mediated N-me(3)CENP-A [44]. Here, CENPA is linked to colorectal cancer.